PREVENTIVE ACTION OF ORLISTAT ON CARDIOVASCULAR RISKS IN YOUNG OBESITY PATIENTS
Aim. To study the dynamics of cardiovascular risk factors in younger patients with obesity at the background of orlistat reception (Xenalten® 120 mg). Material and methods. The prospective study is done of the orlistat usage among 189 women and men at the age 18-44 y.o. during 3 years, of those 107...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2015-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/245 |